UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000052206 |
|---|---|
| Receipt number | R000059576 |
| Scientific Title | Effect of Weight Loss Following Roux-en-Y Gastric Bypass on Cancer Risk: A Mendelian Randomization Study |
| Date of disclosure of the study information | 2023/09/14 |
| Last modified on | 2023/09/14 01:54:25 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Effect of Weight Loss Following Roux-en-Y Gastric Bypass on Cancer Risk: A Mendelian Randomization Study
Acronym
Effect of Weight Loss Following Roux-en-Y Gastric Bypass on Cancer Risk: A Mendelian Randomization Study
Scientific Title
Effect of Weight Loss Following Roux-en-Y Gastric Bypass on Cancer Risk: A Mendelian Randomization Study
Scientific Title:Acronym
Effect of Weight Loss Following Roux-en-Y Gastric Bypass on Cancer Risk: A Mendelian Randomization Study
Region
| Asia(except Japan) |
Condition
Condition
Weight Loss; Roux-en-Y Gastric Bypass; Cancer; Mendelian Randomization
Classification by specialty
| Gastroenterology | Gastrointestinal surgery |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
The impact of weight loss after RYGB on cancer risk
Basic objectives2
PK,PD
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
The impact of weight loss after RYGB on cancer risk
Key secondary outcomes
Base
Study type
Others,meta-analysis etc
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
GWAS datasets with a large number of participants
Key exclusion criteria
GWAS datasets containing populations of different ancestries
Target sample size
Research contact person
Name of lead principal investigator
| 1st name | Liming |
| Middle name | |
| Last name | Tang |
Organization
Changzhou No.2 People's Hospital Affiliated to Nanjing Medical University
Division name
Department of Gastrointestinal Surgery
Zip code
213100
Address
China.
TEL
15141838858
drtangliming@163.com
Public contact
Name of contact person
| 1st name | Jiaming |
| Middle name | |
| Last name | Xue |
Organization
Changzhou No.2 People's Hospital Affiliated to Nanjing Medical University
Division name
Department of Gastrointestinal Surgery
Zip code
213100
Address
Changzhou City, Jiangsu Province, China
TEL
15141838858
Homepage URL
xuejiaming950410@163.com
Sponsor or person
Institute
Changzhou No.2 People's Hospital Affiliated to Nanjing Medical University
Institute
Department
Personal name
Funding Source
Organization
Changzhou Sci&Tech Program;Changzhou Medical Center of Nanjing Medical University Program
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Changzhou No.2 People's Hospital Affiliated to Nanjing Medical University
Address
No.68 Gehu Middle Road, Changzhou City, Jiangsu Province, China.
Tel
15141838858
xuejiaming950410@163.com
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2023 | Year | 09 | Month | 14 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
0
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2023 | Year | 09 | Month | 14 | Day |
Date of IRB
| 2023 | Year | 09 | Month | 14 | Day |
Anticipated trial start date
| 2023 | Year | 09 | Month | 14 | Day |
Last follow-up date
| 2023 | Year | 09 | Month | 14 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Ethical approval: No ethical approval or informed consent statement was required for this type of article.
Management information
Registered date
| 2023 | Year | 09 | Month | 14 | Day |
Last modified on
| 2023 | Year | 09 | Month | 14 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000059576
